Clinical Trial: PSTC100 Study in Healthy Adult Subjects

U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07752472) titled 'PSTC100 Study in Healthy Adult Subjects' on Aug. 03.

Brief Summary: This study is a single-center, randomized, double-blind, placebo-controlled, dose-escalation phase I clinical trial designed to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic (PD) characteristics of PSTC100 in healthy adult subjects.

Study Start Date: Sept. 07

Study Type: INTERVENTIONAL

Condition: Healthy Adult Subjects

Intervention: DRUG: PSTC100 tablets

PSTC100 tablets: 25 mg, 50 mg, 100 mg, 200 mg, 300 mg, 400 mg

DRUG: PSTC100 tablets

100 mg once daily, 200 mg once daily, 300 mg once daily

Recruitment Status: NOT_YET_RECRUITING ...